novel therapies in low-risk mds
Published 2 years ago • 628 plays • Length 4:12Download video MP4
Download video MP3
Similar videos
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
2:43
novel therapies in the future of mds treatment
-
1:27
novel targets in low-risk mds
-
1:41
novel therapies for high-risk mds
-
1:20
the current standard of care for patients with lower-risk mds
-
3:38
a new set of treatment options for low-risk mds
-
2:54
novel therapies in aml and mds
-
1:22:25
low-risk mds: can we prevent progression?
-
36:35
linc 2023 - treatment of clti: new horizons with novel dcb technology
-
7:51
lower risk mds
-
2:13
major breakthroughs in the field of bpdcn: combination therapies, managing cns involvement & more
-
2:11
new therapeutic options for low-risk mds
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
0:56
the promise of luspatercept for the treatment of lower-risk mds
-
1:32
next-generation sequencing for low-risk mds
-
1:25
novel strategies for treating cytopenia in mds
-
1:02
update on treatments for high- and low-risk mds
-
1:50
considerations for risk-adapted therapy in lower-risk mds
-
3:24
novel agents in higher-risk mds
-
1:32
novel drug targets for mds
-
11:53
the optimal treatment of lower risk mds
-
1:18
the importance risk stratification to enable risk-adapted therapy in mds & cmml